John Hartley

Biography

  John Hartley is advisor to ADC Therapeutics and Professor of Cancer Studies at UCL. He was one of the founders of Spirogen. Prof. Hartley is also Director of the Cancer Research UK Drug-DNA Interactions Research Group and Co-Lead of the UCL Experimental Cancer Medicine Centre. Prior to joining UCL he was a Visiting Fellow at the National Cancer Institute, USA and an Alberta Heritage Research Fellow at the University of Alberta, Canada.  John has a B.Sc. in Biochemistry and a Ph.D. in Experimental Chemotherapy from the University of Manchester. He has over 280 publications in the fields of molecular and clinical pharmacology, DNA damage and repair, drug design and development, and cancer therapeutics. He is a Fellow of both the Royal Societies of Biology and Chemistry and is an Honorary Member of the Royal College of Radiologists. He is also Chair of the Protocol Safely and Review Board of Cancer Research UK.  

Research Interest